Article

Routine vitamin A supplementation for the prevention of blindness due to measles infection in children

Department of Community Medicine, University of Calabar Teaching Hospital, Calabar, Nigeria.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.94). 01/2011; DOI: 10.1002/14651858.CD007719.pub2
Source: PubMed

ABSTRACT Reduced vitamin A concentration increases the risk of blindness in children infected with the measles virus. Promoting vitamin A supplementation in children with measles contributes to the control of blindness in children, which is a high priority within the World Health Organization (WHO) VISION 2020 The Right to Sight Program.
To assess the efficacy of vitamin A in preventing blindness in children with measles without prior clinical features of vitamin A deficiency.
We searched CENTRAL (2011, issue 1), which includes the Cochrane Acute Respiratory Infections Group Specialised Register, MEDLINE (1950 to January 2011), EMBASE.com (1974 to January 2011) and LILACS (1985 to January 2011).
Randomised controlled trials (RCTs) assessing the efficacy of vitamin A in preventing blindness in well-nourished children diagnosed with measles but with no prior clinical features of vitamin A deficiency.
Two review authors independently searched the results for eligible studies and extracted data on reported outcomes. We contacted trial authors of the included studies for additional information on unpublished data. We included two RCTs which were clinically heterogenous. We presented the continuous outcomes reported as the mean difference (MD) with 95% confidence interval (CI). Due to marked clinical heterogeneity we considered it inappropriate to perform a meta-analysis.
Two RCTs involving 260 children with measles which compared vitamin A with placebo met the inclusion criteria. Neither study reported blindness or other ocular morbidities as end points. One trial of moderate quality suggested evidence of a significant increase in serum retinol levels in the vitamin A group one week after two doses of vitamin A (MD 9.45 µg/dL; 95% CI 2.19 to 16.71, 17 participants) but not six weeks after three doses of vitamin A (MD 2.56 µg/dL; 95% CI -5.28 to 10.40; 39 participants). There was no significant difference in weight gain six weeks (MD 0.39 kg; -0.04 to 0.82; 48 participants) and six months (MD 0.52 kg; 95% CI -0.08 to 1.12; 36 participants) after three doses of vitamin A. The second trial found no significant difference in serum retinol levels two weeks after a single dose of vitamin A (MD 2.67 µg/dL; 95% CI -0.29 to 5.63, 155 participants).
We did not find any trials assessing whether or not vitamin A supplementation in children with measles prevents blindness. However, vitamin A use in children should be encouraged for its proven clinical benefits.

0 Followers
 · 
125 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin A deficiency (VAD) is an important cause of blindness and premature death. Red palm oil (RPO) is the richest food source of VA‐forming carotenoids. RPO carotenoid concentration and bioavailability were evaluated and this data used to estimate the amount of RPO needed to meet VA requirements. Amounts ranged from 6.7 to 29.2 g/d (1.5 to 6.5 tsp/d), which are easily consumed. The amount of RPO needed to supply recommended dietary intakes of VA for all 208100000 individuals most in danger for VAD worldwide for 1 y is 0.80 million metric tons, a fraction of annual world palm oil production. Despite its abundance, RPO has seldom been used for VAD prevention on a national level. Pareto charts were constructed to highlight the variables that influence the ability of RPO to prevent VAD on the national level. The most important variable by far was refining method. Most refining methods are designed to remove color and flavor from RPO, resulting in a bland product that lacks carotenoids. Thus, the important barriers to the use of RPO as a food‐based intervention to prevent VAD appear to be that: (1) RPO requires refining, limiting its profitability and availability for small farmers. (2) The goal of most refining methods is to create a low‐cost bland, odorless, and colorless fat which requires removal of carotenoids. (3) Cost, since RPO use competes with high‐dose VA supplements, which are heavily subsidized. It appears that RPO could prevent VAD in many food‐deficit countries if carotenoids were conserved during oil refining, and costs were low enough to make it an attractive alternative to nutritional supplements.
    Comprehensive Reviews in Food Science and Food Safety 03/2012; 11(2). DOI:10.1111/j.1541-4337.2011.00181.x · 3.54 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article describes the background and contribution of The Cochrane Collaboration to the WHO Nutrition Guidelines program. Systematic reviews, augmented by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology for assessing the quality of a body of evidence, form the evidence basis for WHO guidelines. Our shared experience of working together has highlighted a number of issues that are challenging, such as decisions made about selecting appropriate questions for evidence synthesis and the nature of study types that are included, in particular the decision on whether or not to extend a search beyond randomized studies. Although the skills and experience required for evidence synthesis are different from those needed to determine recommendations for policy and practice, our experience suggests that some engagement between the two groups is mutually beneficial. Finally, our experience highlights the recognition that evidence of effectiveness is essential but by no means sufficient to guide decisions on recommendations. Programmatic and implementation considerations are important to guide decision making and the evidence basis for this may be limited; therefore, it is essential that groups involved in delivering interventions to populations are also engaged in the guidelines process.
    Advances in Nutrition 01/2014; 5(1):35-9. DOI:10.3945/an.113.004895 · 3.20 Impact Factor

Full-text (2 Sources)

Download
58 Downloads
Available from
Jun 4, 2014